| 证券代码 | ROSG.O |
| 证券名称 | Rosetta Genomics Ltd |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2007-02-27 |
| 首发价格(元) | 7 USD |
| 首发数量(股) | 3750000 |
| 首发募资额(元) | 26,250,000.00 USD |
| 首发主承销商 | C.E. Unterberg, Towbin LLC |
| 货币单位 | USD |
| 公司名称 | Rosetta Genomics Ltd. |
| 注册地址 | 以色列 |
| 办公地址 | 10 Plaut Street, Science Park, Rehovot, Israel |
| 成立日期 | 2000-03-09 |
| 董事会主席 | Brian A. Markison |
| 公司属地 | Israel 以色列 |
| 公司网址 | www.rosettagenomics.com |
| 电话 | +972 (73) 222-0700 |
| 传真 | - |
| 公司简介 | Rosetta Genomics Ltd. develops and commercializes a full range of microRNA-based molecular diagnostics. Founded in 2000, Rosetta’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta is working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools. Rosetta’s cancer testing services are commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab. |